Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $117,164.00 in Stock

Posted by Brian Himes on Jun 19th, 2026

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 6,800 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $17.23, for a total transaction of $117,164.00. Following the transaction, the chief financial officer owned 187,209 shares in the company, valued at approximately $3,225,611.07. The trade was a 3.50% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Omada Health Trading Up 2.3%

Shares of OMDA opened at $17.64 on Friday. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The firm’s 50 day moving average is $15.73 and its 200-day moving average is $14.78. The stock has a market capitalization of $1.05 billion and a PE ratio of -65.33.

Omada Health (NASDAQ:OMDA – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. Equities research analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on OMDA shares. Morgan Stanley cut their target price on Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a research report on Friday, March 6th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Finally, BMO Capital Markets decreased their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, March 6th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Read Our Latest Analysis on Omada Health

Institutional Trading of Omada Health

Several large investors have recently bought and sold shares of OMDA. Quarry LP bought a new position in Omada Health in the fourth quarter valued at about $29,000. TD Waterhouse Canada Inc. bought a new position in shares of Omada Health in the fourth quarter worth about $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the 2nd quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new stake in shares of Omada Health in the 4th quarter valued at approximately $45,000. Finally, Strs Ohio grew its holdings in shares of Omada Health by 151.0% during the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after purchasing an additional 2,567 shares during the last quarter.

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.